These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2428445)

  • 1. Substance P antagonists in substantia nigra are anticonvulsant.
    Garant DS; Iadarola MJ; Gale K
    Brain Res; 1986 Sep; 382(2):372-8. PubMed ID: 2428445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infusion of opiates into substantia nigra protects against maximal electroshock seizures in rats.
    Garant DS; Gale K
    J Pharmacol Exp Ther; 1985 Jul; 234(1):45-8. PubMed ID: 2989511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lesions of substantia nigra protect against experimentally induced seizures.
    Garant DS; Gale K
    Brain Res; 1983 Aug; 273(1):156-61. PubMed ID: 6616222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticonvulsant action of GABA receptor blockade in the nigrotectal target region.
    Dean P; Gale K
    Brain Res; 1989 Jan; 477(1-2):391-5. PubMed ID: 2539235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant role of nigrotectal projection in the maximal electroshock model of epilepsy--I. Mapping of dorsal midbrain with bicuculline.
    Redgrave P; Simkins M; overton P; Dean P
    Neuroscience; 1992; 46(2):379-90. PubMed ID: 1542413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substantia nigra-mediated anticonvulsant actions: role of nigral output pathways.
    Garant DS; Gale K
    Exp Neurol; 1987 Jul; 97(1):143-59. PubMed ID: 3582559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranigral application of substance P antagonists prevents the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Melis MR; Gale K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 May; 326(1):83-6. PubMed ID: 6206401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of proconvulsant action of GABA depletion in substantia nigra in several seizure models.
    Maggio R; Sohn E; Gale K
    Brain Res; 1991 Apr; 547(1):1-6. PubMed ID: 1650283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of substantia nigra gamma-vinyl-GABA infusions on flurothyl seizures in adult rats.
    Xu SG; Garant DS; Sperber EF; Moshé SL
    Brain Res; 1991 Dec; 566(1-2):108-14. PubMed ID: 1814529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranigral substance P stimulation of striatal dopamine release is inhibited by spantide II: a new tachykinin antagonist without apparent neurotoxicity.
    Reid MS; Hökfelt T; Herrera-Marschitz M; Håkanson R; Feng DM; Folkers K; Goldstein M; Ungerstedt U
    Brain Res; 1990 Nov; 532(1-2):175-81. PubMed ID: 1704289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the substantia nigra in GABA-mediated anticonvulsant actions.
    Gale K
    Adv Neurol; 1986; 44():343-64. PubMed ID: 3010676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticonvulsant effect of intranigral fluoxetine.
    Pasini A; Tortorella A; Gale K
    Brain Res; 1992 Oct; 593(2):287-90. PubMed ID: 1450936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid.
    Iadarola MJ; Gale K
    Science; 1982 Dec; 218(4578):1237-40. PubMed ID: 7146907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranigral muscimol attenuates electrographic signs of seizure activity induced by intravenous bicuculline in rats.
    Garant D; Gale K
    Eur J Pharmacol; 1986 May; 124(3):365-9. PubMed ID: 3732385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seizures evoked from area tempestas are subject to control by GABA and glutamate receptors in substantia nigra.
    Maggio R; Gale K
    Exp Neurol; 1989 Aug; 105(2):184-8. PubMed ID: 2568946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant action of intranigral gamma-vinyl-GABA: role of nonadrenergic neurotransmission.
    Bonhaus DW; McNamara JO
    Brain Res; 1988 Jan; 438(1-2):391-4. PubMed ID: 2830944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant action of 2-amino-7-phosphonoheptanoic acid in the substantia nigra.
    De Sarro G; Meldrum BS; Reavill C
    Eur J Pharmacol; 1984 Oct; 106(1):175-9. PubMed ID: 6529964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence of involvement of substantia nigra GABAB receptors in seizure suppression in developing rats.
    Velísková J; Garant DS; Xu SG; Moshé SL
    Brain Res Dev Brain Res; 1994 Jun; 79(2):297-300. PubMed ID: 7955329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microinjection of a benzodiazepine into substantia nigra elevates kindled seizure threshold.
    King PH; Shin C; Mansbach HH; Chen LS; McNamara JO
    Brain Res; 1987 Oct; 423(1-2):261-8. PubMed ID: 3315121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence implicating alpha-2 adrenergic receptors in the anticonvulsant action of intranigral muscimol.
    Platt K; Butler LS; Bonhaus DW; McNamara JO
    J Pharmacol Exp Ther; 1987 Jun; 241(3):751-4. PubMed ID: 3037068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.